Drosten C, Günther S, Preiser W, et al.Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967-1976.
2.
Poutanen SM, Low DE, Henry B, et al.Identification of severe acute respiratory syndrome in Canada. N Engl J Med. 2003;348:1995-2005.
3.
So LKY, Lau ACW, Yam LYC, et al.Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003;361:1615-1617.
4.
Hon EKL, Leung CW, Cheng WTF, et al.Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet. 2003;361:1701-1703.
5.
World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Accessed at: www.who.int/csr/sars/casedefinition/en/.
6.
Peiris JSM, Chu CM, Cheng VCC, et al.Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-1772.
7.
Chang CH, Chen KY, Lai MY, et al.Meta-analysis: ribavirin-induced haemolytic anemia in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2002;16:1623-1632.
8.
Li CK, Chan PK, Ling SC, et al.Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major. Br J Haematol. 2002;117:755-758.
9.
Joseph BM, Isabel JK, Patricia AW, et al.Lassa fever: effective therapy with ribavirin. N Engl J Med. 1986;314:20-26.